D.A. DAVIDSON & CO. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 185 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2020$225,000
-44.3%
2,310
-29.8%
0.00%
-50.0%
Q2 2020$404,000
-12.2%
3,292
-37.3%
0.01%
-11.1%
Q1 2020$460,000
-20.0%
5,250
-4.5%
0.01%0.0%
Q4 2019$575,000
+24.2%
5,496
+36.6%
0.01%
+12.5%
Q3 2019$463,000
-25.7%
4,024
+11.4%
0.01%
-33.3%
Q2 2019$623,000
+5.8%
3,611
+3.3%
0.01%
+20.0%
Q1 2019$589,000
+89.4%
3,494
+94.0%
0.01%
+66.7%
Q3 2018$311,000
+3010.0%
1,801
+1701.0%
0.01%
Q2 2017$10,000
-16.7%
1000.0%0.00%
Q1 2017$12,000
+9.1%
1000.0%0.00%
Q4 2016$11,000
-15.4%
1000.0%0.00%
Q3 2016$13,0000.0%100
-32.4%
0.00%
Q2 2016$13,000
+85.7%
148
+48.0%
0.00%
Q1 2016$7,000
+16.7%
1000.0%0.00%
Q4 2015$6,000
-33.3%
1000.0%0.00%
Q3 2015$9,000
-25.0%
1000.0%0.00%
Q2 2015$12,000
+33.3%
1000.0%0.00%
Q1 2015$9,0001000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 3,455,054$456,102,0008.18%
Consonance Capital Management LP 675,492$89,172,0008.05%
Prisma Capital Partners LP 33,000$4,356,0004.11%
Broadfin Capital, LLC 122,930$16,228,0002.65%
Rock Springs Capital Management LP 354,000$46,732,0002.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 339,180$44,775,0001.76%
GREAT POINT PARTNERS LLC 75,000$9,901,0001.69%
Atika Capital Management LLC 31,000$4,092,0001.58%
Sivik Global Healthcare LLC 30,000$3,960,0001.47%
Sio Capital Management, LLC 19,000$2,508,0001.41%
View complete list of GW PHARMACEUTICALS PLC shareholders